Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) - Research analysts at Barrington Research decreased their Q2 2025 EPS estimates for shares of Cross Country Healthcare in a research note issued on Tuesday, June 17th. Barrington Research analyst K. Steinke now anticipates that the business services provider will post earnings per share of $0.04 for the quarter, down from their prior estimate of $0.09. Barrington Research currently has a "Market Perform" rating and a $18.61 target price on the stock. The consensus estimate for Cross Country Healthcare's current full-year earnings is $0.53 per share. Barrington Research also issued estimates for Cross Country Healthcare's Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.09 EPS and FY2025 earnings at $0.26 EPS.
Several other brokerages also recently issued reports on CCRN. UBS Group reduced their price target on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating for the company in a report on Tuesday, May 13th. Wall Street Zen initiated coverage on shares of Cross Country Healthcare in a research note on Thursday, May 15th. They set a "hold" rating for the company. Seven equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat, Cross Country Healthcare presently has an average rating of "Hold" and a consensus target price of $17.93.
View Our Latest Research Report on CCRN
Cross Country Healthcare Price Performance
Shares of CCRN opened at $14.25 on Thursday. Cross Country Healthcare has a 12 month low of $9.58 and a 12 month high of $18.50. The stock has a fifty day moving average price of $13.70 and a 200 day moving average price of $15.88. The company has a market cap of $467.12 million, a P/E ratio of -26.89, a PEG ratio of 4.08 and a beta of 0.37.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last issued its earnings results on Wednesday, May 7th. The business services provider reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 1.41% and a positive return on equity of 2.56%. During the same period in the previous year, the company earned $0.19 EPS. The firm's quarterly revenue was down 22.6% on a year-over-year basis.
Institutional Investors Weigh In On Cross Country Healthcare
Several institutional investors have recently bought and sold shares of CCRN. Strs Ohio acquired a new position in Cross Country Healthcare during the 1st quarter valued at about $536,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Cross Country Healthcare by 7.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 115,823 shares of the business services provider's stock worth $1,725,000 after purchasing an additional 8,490 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in Cross Country Healthcare by 56.9% in the first quarter. Goldman Sachs Group Inc. now owns 1,095,178 shares of the business services provider's stock worth $16,307,000 after purchasing an additional 397,216 shares during the period. PenderFund Capital Management Ltd. increased its position in shares of Cross Country Healthcare by 5.4% during the 1st quarter. PenderFund Capital Management Ltd. now owns 27,100 shares of the business services provider's stock valued at $404,000 after purchasing an additional 1,400 shares during the period. Finally, Alliancebernstein L.P. boosted its stake in Cross Country Healthcare by 82.4% during the first quarter. Alliancebernstein L.P. now owns 2,343,484 shares of the business services provider's stock valued at $34,894,000 after buying an additional 1,058,544 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
About Cross Country Healthcare
(
Get Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.